Thyrocare Technologies Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Thyrocare Technologies Ltd. from all sources in a single place.

Thyrocare Technologies Ltd.

19 Sep 2025

1205.90

0.94%

SAST

Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 18, 2025 for Docon Technologies Pvt Ltd & PACs

pdf

Thyrocare Technologies Ltd.

19 Sep 2025

1205.90

0.94%

SAST

Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd

pdf

Thyrocare Technologies Ltd.

19 Sep 2025

1205.90

0.94%

SAST

Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Docon Technologies Pvt Ltd & PACs

pdf

Thyrocare Technologies Ltd.

19 Sep 2025

1205.90

0.94%

SAST

Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd

pdf

Thyrocare Technologies Ltd.

18 Sep 2025

1205.90

0.94%

SAST

Thyrocare Technologies Ltd - 539871 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL (India) Ltd

pdf

Thyrocare Technologies Ltd.

15 Sep 2025

1205.90

0.94%

Thyrocare Tech Parent Company Proposes Issuing NCDs Worth Rs 1,700 Crore

NDTV Profit

An NCD is a fixed-income instrument that provides structured returns to investors.

Thyrocare Technologies Ltd. has gained 62.74% in the last 6 Months

Thyrocare Technologies Ltd.

15 Sep 2025

1205.90

0.94%

Corp. Note

Thyrocare Technologies Ltd - 539871 - Disclosure under Regulation 30A of LODR

BSE India

Please find attached herewith Disclosures regarding Regulation 30 read with Regulation 30A and Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf